Related Experiment Video
Updated: Jun 2, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Inflammation and thrombosis in diabetes
Katharina Hess1, Peter J Grant
1Division of Cardiovascular and Diabetes Research, Leeds Institute of Genetics, Health and Therapeutics, LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds, UK.
Thrombosis and Haemostasis
|April 12, 2011
Summary
Patients with diabetes have a heightened risk of cardiovascular events due to a prothrombotic state. This increases cardiovascular mortality and reduces antithrombotic therapy effectiveness.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Endocrinology
Background:
- Patients with diabetes mellitus face elevated risks of cardiovascular morbidity and mortality.
- Atherothrombosis, characterized by atherosclerotic lesion disruption and thrombus formation, is a leading cause of death in diabetic individuals.
- Diabetic patients exhibit a prothrombotic state involving hyper-reactive platelets, increased pro-thrombotic markers, and impaired fibrinolysis.
Purpose of the Study:
- To elucidate the mechanisms underlying the prothrombotic state in diabetes.
- To understand the impact of insulin resistance, dysglycemia, and inflammation on thrombotic risk.
- To highlight the implications for cardiovascular risk and antithrombotic therapy efficacy.
Main Methods:
- Review of existing literature on diabetes, atherothrombosis, and hemostasis.
- Analysis of the interplay between metabolic and inflammatory factors in platelet and coagulation pathways.
- Examination of the effects on clot structure and fibrinolysis.
Main Results:
- Diabetes is associated with hyper-reactive platelets and increased pro-thrombotic markers.
- Insulin resistance, dysglycemia, and inflammation significantly contribute to this prothrombotic state.
- The prothrombotic state affects platelet function, coagulation factors, and clot structure, leading to impaired fibrinolysis.
Conclusions:
- The prothrombotic state in diabetes significantly elevates cardiovascular risk.
- This state may explain the diminished response to standard antithrombotic therapies.
- Optimized antithrombotic strategies are crucial for reducing cardiovascular mortality in diabetic patients.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...